## Abstract ## Objective Ankylosing spondylitis (AS) diagnosis is often delayed. The availability of effective biologic agents for treating AS has increased the importance of early diagnosis. We tested questions derived from a comprehensive literature review and an advisory board in a caseโcontrol
Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index
โ Scribed by Maksymowych, Walter P. ;Mallon, Cathy ;Richardson, Rhonda ;Conner-Spady, Barbara ;JaureguI, Edwin ;Chung, Cecilia ;Zappala, Lisa ;Pile, Kevin ;Russell, Anthony S.
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 112 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objectives To define what expert clinicians consider a dramatic response in ankylosing spondylitis (AS) patients treated with biologic therapies based on patient and physician assessments of global disease activity. To compare this expert clinicianโderived criteria to the Ankylosing
## Abstract ## Objective The Patient Acceptable Symptom State (PASS) constitutes an absolute level of patient wellโbeing and represents an ambitious target for disease management. We explored contributors to PASS, validated the PASS concept, and assessed thresholds of selfโreported outcomes below